Disclosures for "Towards Identifying an Optimal Time for Amyloid Assessment with Donanemab Treatment"
-
Dr. Brosch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Brosch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Brosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Brosch has stock in Monument Biosciences. The institution of Dr. Brosch has received research support from Alnylam Pharmaceuticals. The institution of Dr. Brosch has received research support from Athira Pharmaceuticals. The institution of Dr. Brosch has received research support from Biogen. The institution of Dr. Brosch has received research support from EISAI. The institution of Dr. Brosch has received research support from F. Hoffman La-Roche. The institution of Dr. Brosch has received research support from University of Southern California. The institution of Dr. Brosch has received research support from Washington University. Dr. Brosch has received publishing royalties from a publication relating to health care.
-
Dr. Doty has received personal compensation for serving as an employee of Eli Lilly and Company, USA. Dr. Doty has stock in Eli Lilly and Company, USA.
-
Dr. Gueorguieva has stock in Eli Lilly.
-
Dr. Shcherbinin has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Shcherbinin has stock in Eli Lilly and Company. Dr. Shcherbinin has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Chow has received personal compensation for serving as an employee of Eli Lilly and Company. Mr. Chow has stock in Eli Lilly and Company.
-
Ming Lu has received personal compensation for serving as an employee of Eli Lilly and Company. Ming Lu has stock in Eli Lilly and Company.
-
Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
-
Emily Collins has received personal compensation for serving as an employee of Eli Lilly. Emily Collins has stock in Eli Lilly.
-
Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.